Lead the charge in global pricing and market access strategy for a rare disease portfolio, collaborating with cross-functional teams to ensure effective access and value proposition development for current and future products.

Champion strategic growth by leading business development initiatives in the biopharmaceutical sector. Drive opportunity evaluation, deal execution, and cross-functional collaboration to enhance portfolio strategy and foster impactful partnerships.

Transform customer engagement by leading the strategy for consent, identity, and preference management across diverse commercial channels, ensuring compliance and enhancing customer experiences at scale.

Elevate CMC digital transformation by leading IT solutions, enhancing compliance, and driving operational excellence. Collaborate with cross-functional teams to implement scalable, efficient processes from development to commercial launch.

Take ownership of patient access by educating healthcare providers on reimbursement processes, addressing barriers, and collaborating with cross-functional teams to ensure timely treatment and support for Alnylam products.